Regulation of the transcription of G protein-coupled receptor genes

Neuromethods

Volumn 60, Issue , 2011, Pages 49-69

  Hwang, Cheol Kyu ^a   Law, Ping Yee ^b   Wei, Li Na ^b   Loh, Horace H ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

ChIP on chip; Chromatin immunoprecipitation; Electrophoretic mobility shift assay; Epigenetic; G protein coupled receptor; Gene expression; Histone

Indexed keywords

AFFINITY CHROMATOGRAPHY; ANALYTIC METHOD; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; DNA FOOTPRINTING; DNA METHYLATION; DNA MICROARRAY; EPIGENETICS; G PROTEIN COUPLED RECEPTOR GENE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE SILENCING; IMMUNOFLUORESCENCE; IN SITU HYBRIDIZATION; MICROARRAY ANALYSIS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; TRANSCRIPTION REGULATION;

MAMMALIA;

EID: 79960960420     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-61779-179-6_4     Document Type: Article

References (84)

1. Vassilatis DK, Hohmann JG, Zeng H et al (2003) The G protein-coupled receptor repertoires of human and mouse. Proc Natl Acad Sci USA 100:4903-4908 (Pubitemid 36457826)
2. Lundstrom K (2009) An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs. Methods Mol Biol 552:51-66
3. Fredriksson R, Lagerstrom MC, Lundin LG et al (2003) The G-protein-coupled receptors in the human genome form fve main families. Phylogenetic analysis, paralogon groups, and fngerprints. Mol Pharmacol 63:1256-1272 (Pubitemid 36627220)
4. Stevens CW (2009) The evolution of vertebrate opioid receptors. Front Biosci 14:1247-1269
5. Lemon B, Tjian R (2000) Orchestrated response: a symphony of transcription factors for gene control. Genes Dev 14:2551-2569
6. Hsieh J, Gage FH (2005) Chromatin remodeling in neural development and plasticity. Curr Opin Cell Biol 17:664-671 (Pubitemid 41540418)
7. Lomvardas S, Thanos D (2002) Opening chromatin. Mol Cell 9:209-211 (Pubitemid 34195547)
8. Mansour A, Fox CA, Akil H et al (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22-29
9. Hwang CK, Song KY, Kim CS et al (2009) Epigenetic programming of mu opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodeling factor. J Cell Mol Med 13:3591-3615.
10. Chen HC, Wei LN, Loh HH (1999) Expression of mu-, kappa-and delta-opioid receptors in P19 mouse embryonal carcinoma cells. Neuroscience 92:1143-1155 (Pubitemid 29287558)
11. Hwang CK, Song KY, Kim CS et al (2007) Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters. Mol Cell Biol 27:4720-4736
12. Suzuki S, Miyagi T, Chuang TK et al (2000) Morphine upregulates mu opioid receptors of human and monkey lymphocytes. Biochem Biophys Res Commun 279:621-628 (Pubitemid 32016764)
13. Ruzicka BB, Akil H (1997) The interleukin-1beta-mediated regulation of proenkephalin and opioid receptor messenger RNA in primary astrocyte-enriched cultures. Neuroscience 79:517-524 (Pubitemid 27232408)
14. Chang SL, Felix B, Jiang Y et al (2001) Actions of endotoxin and morphine. Adv Exp Med Biol 493:187-196 (Pubitemid 34020227)
15. Azaryan AV, Clock BJ, Rosenberger JG et al (1998) Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration. Can J Physiol Pharmacol 76:278-283 (Pubitemid 28337025)
16. Delfs JM, Yu L, Ellison GD et al (1994) Regulation of mu-opioid receptor mRNA in rat globus pallidus: effects of enkephalin increases induced by short-and long-term haloperidol administration. J Neurochem 63:777-780
17. Antequera F (2003) Structure, function and evolution of CpG island promoters. Cell Mol Life Sci 60:1647-1658 (Pubitemid 37041363)
18. Kouzarides T (2007) Chromatin modifcations and their function. Cell 128:693-705
19. Mito Y, Henikoff JG, Henikoff S (2005) Genome-scale profling of histone H3.3 replacement patterns. Nat Genet 37:1090-1097 (Pubitemid 41486661)
20. Struhl K (1998) Histone acetylation and tran-scriptional regulatory mechanisms. Genes Dev 12:599-606 (Pubitemid 28134293)
21. Zegerman P, Canas B, Pappin D et al (2002) Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex. J Biol Chem 277:11621-11624 (Pubitemid 34952711)
22. Lachner M, O'Carroll D, Rea S et al (2001) Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410:116-120 (Pubitemid 32225847)
23. Fuks F, Hurd PJ, Wolf D et al (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278:4035-4040 (Pubitemid 36801137)
24. Fire A, Xu S, Montgomery MK et al (1998) Potent and specifc genetic interference by double-stranded RNA in Caenorhabditis ele-gans. Nature 391:806-811 (Pubitemid 28099681)
25. Mello CC, Conte D, Jr. (2004) Revealing the world of RNA interference. Nature 431:338-342 (Pubitemid 39265673)
26. Holmquist GP, Ashley T (2006) Chromosome organization and chromatin modifcation: infuence on genome function and evolution. Cytogenet Genome Res 114:96-125 (Pubitemid 44034446)
27. Smith CL, Hager GL (1997) Transcriptional regulation of mammalian genes in vivo. A tale of two templates. J Biol Chem 272: 27493-27496 (Pubitemid 27473531)
28. Carey M, Peterson CL, Smale ST (2009) Transcriptional regulation in eukaryotes: concepts, strategies, and techniques, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
29. Hu X, Cao S, Loh HH et al (1999) Promoter activity of mouse kappa opioid receptor gene in transgenic mouse. Brain Res Mol Brain Res 69:35-43 (Pubitemid 29238184)
30. O'Neill LP, Turner BM (1996) Immuno-precipitation of chromatin. Methods Enzymol 274:189-197
31. Lee TI, Johnstone SE, Young RA (2006) Chromatin immunoprecipitation and microar-ray-based analysis of protein location. Nat Protoc 1:729-748
32. Wei CL, Wu Q, Vega VB et al (2006) A global map of p53 transcription-factor binding sites in the human genome. Cell 124:207-219 (Pubitemid 43069320)
33. Barski A, Cuddapah S, Cui K et al (2007) High-resolution profling of histone methylations in the human genome. Cell 129:823-837 (Pubitemid 46802390)
34. Park SW, Huq MD, Loh HH et al (2005) Retinoic acid-induced chromatin remodeling of mouse kappa opioid receptor gene. J Neurosci 25:3350-3357 (Pubitemid 40471343)
35. Wei LN (2008) Epigenetic control of the expression of opioid receptor genes. Epigenetics 3:119-121
36. Collas P (2009) Chromatin immunoprecipita-tion assays: methods and protocols, Humana Press, Totowa, New Jersey.
37. Ren B, Robert F, Wyrick JJ et al (2000) Genome-wide location and function of DNA binding proteins. Science 290:2306-2309 (Pubitemid 32041573)
38. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
39. Smirnov D, Im HJ, Loh HH (2001) Delta-opioid receptor gene: effect of Sp1 factor on transcriptional regulation in vivo. Mol Pharmacol 60:331-340 (Pubitemid 32678298)
40. Bi J, Hu X, Loh HH et al (2001) Regulation of mouse kappa opioid receptor gene expression by retinoids. J Neurosci 21:1590-1599 (Pubitemid 32182199)
41. Pan YX, Xu J, Bolan E et al (2005) Identifcation of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol Pharmacol 68:866-875 (Pubitemid 41206043)
42. Kim SS, Pandey KK, Choi HS et al (2005) Poly(C) binding protein family is a transcription factor in mu-opioid receptor gene expression. Mol Pharmacol 68:729-736 (Pubitemid 41206026)
43. Dorak MT (2006) Real-time PCR, Taylor & Francis, New York.
44. Song KY, Hwang CK, Kim CS et al (2007) Translational repression of mouse mu opioid receptor expression via leaky scanning. Nucleic Acids Res 35:1501-1513 (Pubitemid 46592872)
45. Gilsbach R, Kouta M, Bonisch H et al (2006) Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. Biotechniques 40:173-177 (Pubitemid 46542637)
46. Pfaff MW (2001) A new mathematical model for relative quantifcation in real-time RT-PCR. Nucleic Acids Res 29:e45
47. Hwang CK, D'Souza UM, Eisch AJ et al (2001) Dopamine receptor regulating factor, DRRF: a zinc fnger transcription factor. Proc Natl Acad Sci USA 98:7558-7563 (Pubitemid 32567987)
48. Choi HS, Song KY, Hwang CK et al (2008) A proteomics approach for identifcation of single strand DNA-binding proteins involved in transcriptional regulation of mouse mu opioid receptor gene. Mol Cell Proteomics 7:1517-1529
49. Kim CS, Choi HS, Hwang CK et al (2006) Evidence of the neuron-restrictive silencer factor (NRSF) interaction with Sp3 and its synergic repression to the mu opioid receptor (MOR) gene. Nucleic Acids Res 34:6392-6403 (Pubitemid 46017939)
50. Tost J (2009) DNA methylation: methods and protocols, 2nd ed., Humana Press, Totowa, New Jersey.
51. Ausubel FM. (2003) Current protocols in molecular biology. Wiley, New York.
52. Lee TI, Rinaldi NJ, Robert F et al (2002) Transcriptional regulatory networks in Saccharomyces cerevisiae. Science 298:799-804 (Pubitemid 35231527)
53. Bar-Joseph Z, Gerber GK, Lee TI et al (2003) Computational discovery of gene modules and regulatory networks. Nat Biotechnol 21:1337-1342 (Pubitemid 37356619)
54. Kirigiti P, Yang YF, Li X et al (2000) Rat beta1-adrenergic receptor regulatory region containing consensus AP-2 elements recognizes novel transactivator proteins. Mol Cell Biol Res Commun 3:181-192 (Pubitemid 30430019)
55. Tseng YT, Stabila JP, Nguyen TT et al (2001) A novel glucocorticoid regulatory unit mediates the hormone responsiveness of the beta1-adrenergic receptor gene. Mol Cell Endocrinol 181:165-178 (Pubitemid 32703758)
56. Lee K, Richardson CD, Razik MA et al (1998) Multiple potential regulatory elements in the 5' fanking region of the human alpha1a-adrenergic receptor. DNA Seq 8:271-276 (Pubitemid 29172939)
57. Bahouth SW, Beauchamp MJ, Vu KN (2002) Reciprocal regulation of beta(1)-adrenergic receptor gene transcription by Sp1 and early growth response gene 1: induction of EGR-1 inhibits the expression of the beta(1)-adrenergic receptor gene. Mol Pharmacol 61:379-390 (Pubitemid 34112813)
58. Malbon CC, Hadcock JR (1988) Evidence that glucocorticoid response elements in the 5'-noncoding region of the hamster beta 2-adrenergic receptor gene are obligate for glucocorticoid regulation of receptor mRNA levels. Biochem Biophys Res Commun 154:676-681
59. Ko JL, Loh HH (2005) Poly C binding protein, a single-stranded DNA binding protein, regulates mouse mu-opioid receptor gene expression. J Neurochem 93:749-761 (Pubitemid 40617634)
60. Hwang CK, Wu X, Wang G et al (2003) Mouse mu opioid receptor distal promoter transcrip-tional regulation by SOX proteins. J Biol Chem 278:3742-3750 (Pubitemid 36801100)
61. Kraus J, Borner C, Giannini E et al (2003) The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene. Mol Pharmacol 64:876-884 (Pubitemid 37153056)
62. Hwang CK, Kim CS, Choi HS et al (2004) Transcriptional regulation of mouse mu opioid receptor gene by PU.1. J Biol Chem 279:19764-19774 (Pubitemid 38623415)
63. Kim CS, Hwang CK, Choi HS et al (2004) Neuron-restrictive silencer factor (NRSF) functions as a repressor in neuronal cells to regulate the mu opioid receptor gene. J Biol Chem 279:46464-46473
64. Andria ML, Simon EJ (2001) Identifcation of a neurorestrictive suppressor element (NRSE) in the human mu-opioid receptor gene. Brain Res Mol Brain Res 91:73-80 (Pubitemid 32702005)
65. Liu HC, Shen JT, Augustin LB et al (1999) Transcriptional regulation of mouse delta-opi-oid receptor gene. J Biol Chem 274:23617-23626
66. Woltje M, Kraus J, Hollt V (2000) Regulation of mouse delta-opioid receptor gene transcription: involvement of the transcription factors AP-1 and AP-2. J Neurochem 74:1355-1362 (Pubitemid 30163954)
67. Sun P, Loh HH (2003) Transcriptional regulation of mouse delta-opioid receptor gene. Ikaros-2 and upstream stimulatory factor syn-ergize in trans-activating mouse delta-opioid receptor gene in T cells. J Biol Chem 278:2304-2308 (Pubitemid 36801300)
68. Li J, Park SW, Loh HH et al (2002) Induction of the mouse kappa-opioid receptor gene by retinoic acid in P19 cells. J Biol Chem 277:39967-39972 (Pubitemid 35190984)
69. Park SW, Li J, Loh HH et al (2002) A novel signaling pathway of nitric oxide on transcrip-tional regulation of mouse kappa opioid receptor gene. J Neurosci 22:7941-7947 (Pubitemid 35379099)
70. Hu X, Bi J, Loh HH et al (2001) An intronic Ikaros-binding element mediates retinoic acid suppression of the kappa opioid receptor gene, accompanied by histone deacetylation on the promoters. J Biol Chem 276:4597-4603
71. Minowa MT, Minowa T, Mouradian MM (1993) Activator region analysis of the human D1A dopamine receptor gene. J Biol Chem 268:23544-23551 (Pubitemid 23328084)
72. Yang Y, Hwang CK, Junn E et al (2000) ZIC2 and Sp3 repress Sp1-induced activation of the human D1A dopamine receptor gene. J Biol Chem 275:38863-38869 (Pubitemid 32009224)
73. Lee SH, Mouradian MM (1999) Up-regulation of D1A dopamine receptor gene transcription by estrogen. Mol Cell Endocrinol 156:151-157 (Pubitemid 29460754)
74. Yajima S, Lee SH, Minowa T et al (1998) Sp family transcription factors regulate expression of rat D2 dopamine receptor gene. DNA Cell Biol 17:471-479 (Pubitemid 28265136)
75. Bontempi S, Fiorentini C, Busi C et al (2007) Identifcation and characterization of two nuclear factor-kappaB sites in the regulatory region of the dopamine D2 receptor. Endocrinology 148:2563-2570 (Pubitemid 46997070)
76. Wang J, Miller JC, Friedhoff AJ (1997) Differential regulation of D2 receptor gene expression by transcription factor AP-1 in cultured cells. J Neurosci Res 50:23-31 (Pubitemid 27433349)
77. Pepitoni S, Wood IC, Buckley NJ (1997) Structure of the M1 muscarinic acetylcholine receptor gene and its promoter. J Biol Chem 272:17112-17117 (Pubitemid 27289820)
78. Rosoff ML, Nathanson NM (1998) GATA factor-dependent regulation of cardiac M2 muscarinic acetylcholine gene transcription. J Biol Chem 273:9124-9129 (Pubitemid 28176202)
79. Laszlo GS, Rosoff ML, Amieux PS et al (2006) Multiple promoter elements required for leukemia inhibitory factor-stimulated M2 musca-rinic acetylcholine receptor promoter activity. J Neurochem 98:1302-1315 (Pubitemid 44127803)
80. Saffen D, Mieda M, Okamura M et al (1999) Control elements of muscarinic receptor gene expression. Life Sci 64:479-486 (Pubitemid 29066696)
81. Rivkees SA, Chen M, Kulkarni J et al (1999) Characterization of the murine A1 adenosine receptor promoter, potent regulation by GATA-4 and Nkx2.5. J Biol Chem 274:14204-14209
82. Ren H, Stiles GL (1998) A single-stranded DNA binding site in the human A1 adenosine receptor gene promoter. Mol Pharmacol 53:43-51 (Pubitemid 28068371)
83. Nie Z, Mei Y, Ford M et al (1998) Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B. Mol Pharmacol 53:663-669 (Pubitemid 28196488)
84. Ren H, Stiles GL (1999) Dexamethasone stimulates human A1 adenosine receptor (A1AR) gene expression through multiple regulatory sites in promoter B. Mol Pharmacol 55:309-316 (Pubitemid 29076028)